Patients Keeping stigma out of it: Personalising the mental health co... Thursday 10th October was World Mental Health Day, focused this year on ‘mental health at work’.
Views & Analysis A problem combination? Leela Barham takes stock of past NICE decisions for combinations to explore the scale of the reimbursement challenge for combination therapies.
Partner Content Partner Content When science and biology combine – the outlook for ADCs in c... Antibody Drug Conjugates (ADCs) are treatments formed by the conjugation of monoclonal antibodies and cytotoxic agents.
News NICE relents on Takeda colorectal cancer drug Fruzaqla Colorectal cancer patients could soon have access via the NHS to a targeted oral drug that can give them more precious time with their loved ones.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
